Wallsti
Macro Next
Meme ranking

IBRX

ImmunityBio, Inc. · Healthcare · Biotechnology
TECHStrong BuyMABuyZACKSHold R500#1 today TARGET+26%
$10.28 +10.83% today · +21.86% 1W
Oct 2 close or latest
PreviewWhy it's moving

Outperforming without a clear catalyst yet

Assembled from Wallsti's own signals.

Key facts

Market cap
$10.9B
Held by institutions
19.8%
Short interest
31.3%
52-week range
1.95–12.43
Analyst mean target
$13.00
Next earnings
Nov 3 est.
Forward P/E
-73.5

Recent events

Earnings ▼
2Q2026 results: EPS −$0.22 vs −$0.08 expected miss −$0.14; next session -2.8% (-4.6 vs SPY)
Insider ▼
Cheryl Cohen (Director) sold 131,210 shares ($1.2M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing
Insider ▼
Christobel Selecky (Director) sold 159,478 shares ($1.4M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing
Insider ▼
Christobel Selecky (Director) sold 96,722 shares ($871.2K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing
Insider ▼
Barry J. Simon (Director) sold 25,000 shares ($196.9K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing
Insider ▼
Barry J. Simon (Director) sold 23,033 shares ($165.3K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filing
Analyst
HC Wainwright & Co. reiterated Buy, target $15.00
Analyst
BTIG reiterated Buy, target $12.00
Analyst
HC Wainwright & Co. reiterated Buy, target $15.00
Earnings ▼
1Q2026 results: EPS −$0.08 vs −$0.07 expected miss −$0.01; revenue $44.2M; next session -7.4% (-7.1 vs SPY)

Analysts · Earnings · Insiders & Congress